Healthcare product companies Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
20:36
May 05
Chip Rewey CIO, Rewey Asset Management The David Lin Report
Healthcare product companies face tariff headwinds.
Healthcare has been surprisingly less resilient than usual, especially product companies, because they have significant global manufacturing exposure in places like Costa Rica and China and therefore face a meaningful tariff impact; the stocks are holding in but the sector is not as defensive as expected.
MED

About Healthcare product companies Investor Commentary

Across the available history and selected sources, Buzzberg tracks Healthcare product companies across 1 sources: 0 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Chip Rewey.